Oct 5, 2018 Inotersen Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis Inotersen Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis... educational initiative for a diagnostic evaluation of this disease to get into the walls of the workflow of neurologists and cardiologists in practice. Now ... read morePublished on 2018-10-05